药物信息为TALWIN INJECTION PENTAZOCINE LACTATE INJECTION, USP (Hospira, Inc.): HOW SUPPLIED
- DESCRIPTION
- CLINICAL PHARMACOLOGY
- INDICATIONS AND USAGE
- CONTRAINDICATION
- WARNINGS
- PRECAUTIONS
- ADVERSE REACTIONS
- DOSAGE AND ADMINISTRATION
- OVERDOSAGE
- HOW SUPPLIED
- Diseases/Conditions Related to TALWIN INJECTION PENTAZOCINE LACTATE INJECTION, USP (Hospira, Inc.)
- 外部链接相关的TALWIN INJECTION PENTAZOCINE LACTATE INJECTION, USP (Hospira, Inc.)
List
Container
Concentration
Fill
Quantity
1920
Multiple-Dose Vial
30 mg/mL
10 mL
Box of 10
Each mL contains pentazocine lactate equivalent to 30 mg base and 2 mg acetone sodium bisulfite, 1.5 mg sodium chloride, and 1 mg methylparaben as preservative, in Water for Injection.
1941
Ampul
30 mg/mL
1 mL
Uni-Amp®
Pak of 25
Each mL contains pentazocine lactate equivalent to 30 mg base and 2.8 mg sodium chloride, in Water for Injection.
The pH of TALWIN solutions is adjusted between 4 and 5 with lactic acid or sodium hydroxide. The air in the ampuls and vials has been displaced by nitrogen gas.
Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.]
Rev. August, 2006
©Hospira 2006 EN-1267 Printed in USA Hospira, Inc., Lake Forest, IL 60045 USA
- Drug Information Provided by National Library of Medicine (NLM).
